A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children?
Authors:
Open Access
- 18 September 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 7, 371
Abstract
Citrin deficiency initially presents as neonatal intrahepatic cholestasis (NICCD) and often resolves within first year of infancy. Failure to thrive and dyslipidemia caused by citrin deficiency (FTTDCD) has been recently proposed as a novel post-NICCD phenotype and its clinical features are still being established. Herein, we encountered a 2-year-old girl who was hospitalized for intermittent fever lasting 10 days. Besides pneumonia, we observed an NICCD-like phenotype with the presence of liver dysfunction, dyslipidemia, aminoacidemia, organic academia, and extremely high levels of alpha-fetoprotein (AFP). Genetic testing confirmed the diagnosis of citrin deficiency and, liver histology revealed she had already developed cirrhosis. Although, improvement of biochemical parameters and liver histology were observed after treatment that included dietary restrictions and symptomatic treatments, AFP levels remained elevated (>400 ng/ml) during a 3-year follow-up period. Moreover, liver magnetic resonance imaging (MRI) examination performed on the patient at age 5 revealed the development of multiple liver nodules with diffusion restriction on diffusion-weighted imaging (DWI). These observations highly indicate the possibility of hepatocellular carcinoma (HCC). Thus, this case reveals that an NICCD-like phenotype complicated with cirrhosis can exist during FTTDCD stage without any prior signs. It also emphasizes the necessity of monitoring AFP levels during follow-up for citrin deficiency patients with persistently high AFP level after treatment as FTTDCD may progress to HCC. Individualized treatment strategy for patients with FTTDCD also need to be explored.Keywords
This publication has 27 references indexed in Scilit:
- SLC25A13 gene mutations in Taiwanese patients with non-viralhepatocellular carcinomaMolecular Genetics and Metabolism, 2011
- Genotypic and phenotypic features of citrin deficiency: Five-year experience in a Chinese pediatric centerInternational Journal of Molecular Medicine, 2011
- Citrin deficiency and current treatment conceptsMolecular Genetics and Metabolism, 2010
- Neonatal intrahepatic cholestasis caused by citrin deficiency: Clinical and laboratory investigation of 13 subjects in mainland of ChinaDigestive and Liver Disease, 2009
- Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin-deficiency even during the silent periodMolecular Genetics and Metabolism, 2009
- Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD)Journal of Inherited Metabolic Disease, 2007
- Homozygous SLC25A13 Mutation in a Taiwanese Patient with Adult-onset Citrullinemia Complicated with Steatosis and Hepatocellular CarcinomaJournal of the Formosan Medical Association, 2006
- Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate–glutamate carrierHepatology Research, 2005
- Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD)Journal of Human Genetics, 2002
- Genetic mechanisms of hepatocarcinogenesisOncogene, 2002